Advertisement
Advertisement
U.S. markets open in 1 hour 27 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Horizon Technology Finance Corporation (HRZN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.86-0.44 (-4.27%)
At close: 04:00PM EDT
9.94 +0.08 (+0.81%)
Pre-Market: 08:00AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Engulfing Line (Bullish)

Engulfing Line (Bullish)

Previous Close10.30
Open10.25
Bid9.00 x 1000
Ask10.05 x 800
Day's Range9.78 - 10.30
52 Week Range9.78 - 19.08
Volume166,183
Avg. Volume165,109
Market Cap250.27M
Beta (5Y Monthly)1.01
PE Ratio (TTM)8.08
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield1.20 (11.34%)
Ex-Dividend DateOct 17, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
45% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for HRZN

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Horizon Technology Finance Corp
    Daily – Vickers Top Buyers & Sellers for 03/09/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 years agoArgus Research
View more
  • GlobeNewswire

    PDS Biotech Completes $35 Million Financing Agreement Led By Horizon Technology Finance

    Initial tranche of $25 million provides funding in preparation for registrational trial for lead candidate PDS0101Conference call scheduled for Thursday, August 25, 2022 at 8:00 AM EDT FLORHAM PARK, N.J., Aug. 24, 2022 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary Versamune® and Infectimune™ T ce

  • PR Newswire

    InBrace Closes New Round of $45M Financing To Accelerate Growth And Market Expansion

    InBrace, the orthodontic company behind the novel Smartwire® technology, announced that it has closed $45 million in financing led by Horizon Technology Finance Corporation (NASDAQ: HRZN). This new venture loan facility builds off the $100M+ Series D raise in 2021 to continue accelerating InBrace adoption in the $40 billion orthodontics market.

  • PR Newswire

    Horizon Technology Finance Announces Monthly Distributions for October, November and December 2022 Totaling $0.30 per Share

    Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that its board of directors has declared monthly cash distributions of $0.10 per share payable in each of October, November and December 2022. The following table shows these mo

Advertisement
Advertisement